FCP OP MEDICAL BioHealth Trends FCP OP ... - Sal. Oppenheim
FCP OP MEDICAL BioHealth Trends FCP OP ... - Sal. Oppenheim
FCP OP MEDICAL BioHealth Trends FCP OP ... - Sal. Oppenheim
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
SUMMARY<br />
Biotech funds: overview of the top five<br />
DWS Biotech Typ O JB EF Biotech-USD / A<br />
Allianz RCM<br />
Biotechnologie A EUR<br />
DekaLux-BioTech CF<br />
Regeneron Pharma Pharma. 90% 9,0 % Amgen 90% 9,0 % Biogen Idec Inc 89% 8,9 % Regeneron Pharma Pharma. 75% 7,5 %<br />
Alexion Pharma 8,0 % Vertex Pharm. 7,4 % Amgen 7,3 % Alexion Pharma 7,5 %<br />
Gilead Sciences 6,7 % Biogen Idec Inc 7,2 % Celgene 5,7 % Gilead Sciences 5,8 %<br />
Vertex Pharm. 5,7 % Celgene 6,8 % Onyx Pharmaceuticals 5,3 % Celgene 5,5 %<br />
Biogen Idec Inc 5,0 % Regeneron Pharma. 5,6 % Medivation 5,2% Vertex Pharm. 5,0 %<br />
Total Summe of top Top 55 34,4 % Total Summe of top Top 55 36,1 % Total Summe of top Top 55 32,3 % Total Summe of top Top 5 5 31,3 %<br />
Pictet Funds (LUX) (LUX)-Biotech-P Biotech P Cap Cap- UBS (Lux) Equity Fund - Biotech<br />
iSharesNasdaq<br />
<strong>FCP</strong><strong>OP</strong><strong>MEDICAL</strong><strong>BioHealth</strong>-<br />
<strong>FCP</strong> <strong>OP</strong> <strong>MEDICAL</strong> <strong>BioHealth</strong><br />
EUR<br />
(USD) P-acc<br />
Biotechnology Index<br />
<strong>Trends</strong> EUR<br />
Vertex Pharm. 6,8 % Biogen Idec Inc 8,4 % Alexion Pharma 8,2 % Ligand Pharma 6,1 %<br />
Incyte 6,0 % Gilead Sciences 7,6 % Amgen 7,3 % Immunogen 5,8 %<br />
Biogen Idec Inc 5,7 % Amgen 6,7 % Regeneron Pharma. 6,4 % Furiex Pharma 3,8 %<br />
Onyx Pharmaceuticals 5,7 % Vertex Pharm. 5,1 % Gilead Sciences 5,5 % Basilea Pharma N-Akt 2,8 %<br />
Gilead Sciences 5,6 % Celgene 4,7 % Biogen Idec Inc 5,5 % UCB 2,8 %<br />
TTotal SSumme t l of f top tTTop 5 5 298% 29,8 % SSumme TTotal t l of f TTop top t 5 5 324% 32,4 % TTotal SSumme t l of f top tTTop 5 5 33 33,0 0 % TTotal SSumme t l of f top tTTop 5<br />
5 212% 21,2 %<br />
Source: information provided by the respective management company As of: 05/31/2012<br />
As of 06/30/2012: <strong>FCP</strong> <strong>OP</strong> <strong>MEDICAL</strong> <strong>BioHealth</strong>-<strong>Trends</strong> EUR, Allianz RCM Biotechnologie A EUR, iSharesNasdaq Biotechnology Index<br />
06/30/2012| Page 38 <strong>Oppenheim</strong> Asset Management Services S.à r.l.
Change language